1313 related articles for article (PubMed ID: 30006314)
1. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
2. Disassembly of amphiphilic small molecular prodrug with fluorescence switch induced by pH and folic acid receptors for targeted delivery and controlled release.
Xu Z; Shi X; Hou M; Xue P; Gao YE; Liu S; Kang Y
Colloids Surf B Biointerfaces; 2017 Feb; 150():50-58. PubMed ID: 27883931
[TBL] [Abstract][Full Text] [Related]
3. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
4. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
[TBL] [Abstract][Full Text] [Related]
5. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
6. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
7. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
[TBL] [Abstract][Full Text] [Related]
8. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.
Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z
ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426
[TBL] [Abstract][Full Text] [Related]
10. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E-based prodrug self-delivery for nanoformulated irinotecan with synergistic antitumor therapeutics.
Ling L; Ismail M; Shang Z; Hu Y; Li B
Int J Pharm; 2020 Mar; 577():119049. PubMed ID: 31982558
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B
Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952
[TBL] [Abstract][Full Text] [Related]
14. Small Molecular Theranostic Assemblies Functionalized by Doxorubicin-Hyaluronic Acid-Methotrexate Prodrug for Multiple Tumor Targeting and Imaging-Guided Combined Chemo-Photothermal Therapy.
Chen Y; Chen Q; Zhu Q; Liu J; Li Y; Gao X; Chen D; Zhu X
Mol Pharm; 2019 Jun; 16(6):2470-2480. PubMed ID: 30995065
[TBL] [Abstract][Full Text] [Related]
15. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
16. Evaluation the synergistic antitumor effect of methotrexate-camptothecin codelivery prodrug from self-assembly process to acid-catalyzed both drugs release: A comprehensive theoretical study.
Pakdel M; Raissi H; Hosseini ST
J Comput Chem; 2020 Jun; 41(16):1486-1496. PubMed ID: 32190916
[TBL] [Abstract][Full Text] [Related]
17. Self-sensibilized polymeric prodrug co-delivering MMP-9 shRNA plasmid for combined treatment of tumors.
Tang Q; Ma X; Zhang Y; Cai X; Xue W; Ma D
Acta Biomater; 2018 Mar; 69():277-289. PubMed ID: 29369806
[TBL] [Abstract][Full Text] [Related]
18. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
[TBL] [Abstract][Full Text] [Related]
19. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
